within Pharmacolibrary.Drugs.ATC.V;

model V08AB03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 1.3 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ioxaglic acid is an iodinated, low-osmolar, nonionic contrast agent used primarily for radiographic imaging such as angiography, urography, and computed tomography. It is mainly administered as its meglumine or sodium salt (ioxaglate). While once widely used, newer contrast agents with improved safety profiles have reduced its use, but it remains a recognized radiographic contrast medium.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adult subjects with normal renal function after single intravenous administration. No primary clinical PK study was found; values here are approximated based on class similarity and secondary published summaries.</p><h4>References</h4><ol><li><p>Morin, JP, et al., &amp; Fillastre, JP (1987). [Comparative pharmacokinetics and renal accumulation of the iodized contrast media: ioxitalamic acid, ioxaglic acid and iohexol in the rabbit]. <i>Pathologie-biologie</i> 35(9) 1215–1220. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3320896/&quot;>https://pubmed.ncbi.nlm.nih.gov/3320896</a></p></li><li><p>Dean, PB, et al., &amp; Kormano, M (1983). Contrast enhancement pharmacokinetics of six ionic and nonionic contrast media. <i>Investigative radiology</i> 18(4) 368–374. DOI:<a href=&quot;https://doi.org/10.1097/00004424-198307000-00015&quot;>10.1097/00004424-198307000-00015</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6618828/&quot;>https://pubmed.ncbi.nlm.nih.gov/6618828</a></p></li><li><p>Dussol, B, et al., &amp; Berland, Y (2006). A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. <i>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</i> 21(8) 2120–2126. DOI:<a href=&quot;https://doi.org/10.1093/ndt/gfl133&quot;>10.1093/ndt/gfl133</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16611682/&quot;>https://pubmed.ncbi.nlm.nih.gov/16611682</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V08AB03;
